{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:11:08Z","timestamp":1785849068807,"version":"3.56.0"},"reference-count":66,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Despite being responsible for invasive infections, fungal pathogens have been underrepresented in computer aided therapeutic target mining and drug design. Excess of Candida albicans causes candidiasis, causative of thrush and vaginal infection due to off-balance. In this study, we attempted to mine drug targets (n = 46) using a subtractive proteomic approach in this pathogenic yeast and screen natural products with inhibition potential against fructose-bisphosphate aldolase (FBA) of the C. albicans. The top compound selected on the basis of best docking score from traditional Indian medicine\/Ayurvedic library was (4-Hydroxybenzyl)thiocarbamic acid, from the ZINC FBA inhibitor library was ZINC13507461 (IUPAC name: [(2R)-2-hydroxy-3-phosphonooxypropyl] (9E,12E)-octadeca-9,12-dienoate), and from traditional Tibetan medicine\/Sowa rigpa was Chelerythrine (IUPAC name: 1,2-Dimethoxy-12-methyl-9H-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium), compared to the control (2E)-1-(4-nitrophenyl)-2-[(4-nitrophenyl)methylidene]hydrazine. No Ames toxicity was predicted for prioritized compounds while control depicted this toxicity. (4-Hydroxybenzyl)thiocarbamic acid showed hepatotoxicity, while Chelerythrine depicted hERG inhibition, which can lead to QT syndrome, so we recommend ZINC13507461 for further testing in lab. Pharmacological based pharmacokinetic modeling revealed that it has low bioavailability and hence, absorption in healthy state. In cirrhosis and renal impairment, absorption and plasma accumulation increased so we recommend further investigation into this occurrence and recommend high dosage in further tests to increase bioavailability.<\/jats:p>","DOI":"10.3390\/life12111743","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T07:26:50Z","timestamp":1667114810000},"page":"1743","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inferring Therapeutic Targets in Candida albicans and Possible Inhibition through Natural Products: A Binding and Physiological Based Pharmacokinetics Snapshot"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1785-3803","authenticated-orcid":false,"given":"Zarrin","family":"Basharat","sequence":"first","affiliation":[{"name":"Jamil\u2013ur\u2013Rahman Center for Genome Research, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwal","family":"Khan","sequence":"additional","affiliation":[{"name":"Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurshid","family":"Jalal","sequence":"additional","affiliation":[{"name":"HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8678-5029","authenticated-orcid":false,"given":"Sulaiman Mohammed","family":"Alnasser","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Unaizah College of Pharmacy, Qassim University, Buraydah 52571, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sania","family":"Majeed","sequence":"additional","affiliation":[{"name":"Jamil\u2013ur\u2013Rahman Center for Genome Research, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marium","family":"Zehra","sequence":"additional","affiliation":[{"name":"Jamil\u2013ur\u2013Rahman Center for Genome Research, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CMR.00076-09","article-title":"Candida infections of the genitourinary tract","volume":"23","author":"Achkar","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Pellon, A., Begum, N., Sadeghi Nasab, S.D., Harzandi, A., Shoaie, S., and Moyes, D.L. (2022). Role of Cellular Metabolism during Candida-Host Interactions. Pathogens, 11.","DOI":"10.3390\/pathogens11020184"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mib.2019.06.002","article-title":"Candidalysin: Discovery and function in Candida albicans infections","volume":"52","author":"Naglik","year":"2019","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"myab069","DOI":"10.1093\/mmy\/myab069","article-title":"Factors determining the mortality in cirrhosis patients with invasive candidiasis: A systematic review and meta-analysis","volume":"60","author":"Verma","year":"2021","journal-title":"Med. Mycol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Healey, K.R., and Perlin, D.S. (2018). Fungal resistance to echinocandins and the MDR phenomenon in Candida glabrata. J. Fungi, 4.","DOI":"10.20944\/preprints201808.0306.v1"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fmicb.2012.00133","article-title":"Dysregulation of ion homeostasis by antifungal agents","volume":"3","author":"Zhang","year":"2012","journal-title":"Front. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Silva, S., Rodrigues, C.F., Ara\u00fajo, D., Rodrigues, M.E., and Henriques, M. (2017). Candida species biofilms\u2019 antifungal resistance. J. Fungi, 3.","DOI":"10.3390\/jof3010008"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"204237","DOI":"10.1155\/2013\/204237","article-title":"Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents","volume":"2013","author":"Spampinato","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Spettel, K., Barousch, W., Makristathis, A., Zeller, I., Nehr, M., Selitsch, B., Lackner, M., Rath, P., Steinmann, J., and Willinger, B. (2019). Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210397"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-6634-9_5","article-title":"Computer-Aided Drug Design Methods","volume":"1520","author":"Yu","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1359-6446(98)01278-1","article-title":"Computer-aided target selection\u2014Prioritizing targets for antifungal drug discovery","volume":"4","author":"Spaltmann","year":"1999","journal-title":"Drug Discov. Today"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113705","DOI":"10.1016\/j.ejmech.2021.113705","article-title":"Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review","volume":"224","author":"Sabe","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"D677","DOI":"10.1093\/nar\/gkaa917","article-title":"DEG 15, an update of the Database of Essential Genes that includes built-in analysis tools","volume":"49","author":"Luo","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ye, Y.N., Hua, Z.G., Huang, J., Rao, N., and Guo, F.B. (2013). CEG: A database of essential gene clusters. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-769"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"baaa112","DOI":"10.1093\/database\/baaa112","article-title":"CEG 2.0: An updated database of clusters of essential genes including eukaryotic organisms","volume":"2020","author":"Liu","year":"2020","journal-title":"Database"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1073\/pnas.0510013103","article-title":"Essential genes of a minimal bacterium","volume":"103","author":"Glass","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"105004","DOI":"10.1016\/j.meegid.2021.105004","article-title":"Therapeutic target identification via differential genome analysis of antibiotic resistant Shigella sonnei and inhibitor evaluation against a selected drug target","volume":"94","author":"Basharat","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ygeno.2020.12.015","article-title":"Pan-genomics, drug candidate mining and ADMET profiling of natural product inhibitors screened against Yersinia pseudotuberculosis","volume":"113","author":"Basharat","year":"2021","journal-title":"Genomics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"104928","DOI":"10.1016\/j.meegid.2021.104928","article-title":"Comparative genome analysis of Corynebacterium species: The underestimated pathogens with high virulence potential","volume":"93","author":"Nasim","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"105165","DOI":"10.1016\/j.compbiomed.2021.105165","article-title":"Differential analysis of Orientia tsutsugamushi genomes for therapeutic target identification and possible intervention through natural product inhibitor screening","volume":"141","author":"Basharat","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s42485-021-00068-9","article-title":"Prioritization of potential drug targets and antigenic vaccine candidates against Klebsiella aerogenes using the computational subtractive proteome-driven approach","volume":"12","author":"Chakkyarath","year":"2021","journal-title":"J. Proteins Proteom."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Khan, K., Basharat, Z., Jalal, K., Mashraqi, M.M., Alzamami, A., Alshamrani, S., and Uddin, R. (2022). Identification of Therapeutic Targets in an Emerging Gastrointestinal Pathogen Campylobacter ureolyticus and Possible Intervention through Natural Products. Antibiotics, 11.","DOI":"10.3390\/antibiotics11050680"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/acs.jcim.6b00763","article-title":"Structure-Based Rational Design of Novel Inhibitors Against Fructose-1,6-Bisphosphate Aldolase from Candida albicans","volume":"57","author":"Han","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41598-021-03988-0","article-title":"Identification of vaccine and drug targets in Shigella dysenteriae sd197 using reverse vaccinology approach","volume":"12","author":"Jalal","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: Fast, flexible, and free","volume":"26","author":"Lindahl","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/acsomega.1c05788","article-title":"Preferential Solvation Study of the Synthesized Aldose Reductase Inhibitor (SE415) in the {PEG 400 (1) + Water (2)} Cosolvent Mixture and GastroPlus-Based Prediction","volume":"7","author":"Hussain","year":"2022","journal-title":"ACS Omega"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1389200223666220628095616","article-title":"The Development of a Physiologically Based Pharmacokinetic (PBPK) Model of Andrographolide in Mice and Scaling It up to Rats, Dogs and Humans","volume":"23","author":"Talapphetsakun","year":"2022","journal-title":"Curr. Drug Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/EC.00115-06","article-title":"Effects of depleting the essential central metabolic enzyme fructose-1,6-bisphosphate aldolase on the growth and viability of Candida albicans: Implications for antifungal drug target discovery","volume":"5","author":"Rodaki","year":"2006","journal-title":"Eukaryot. Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: Human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"fuaa060","DOI":"10.1093\/femsre\/fuaa060","article-title":"The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: Current knowledge and new perspectives","volume":"45","author":"Kaune","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"a019273","DOI":"10.1101\/cshperspect.a019273","article-title":"The spectrum of fungi that infects humans","volume":"5","author":"Casadevall","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sun, L., Liao, K., and Wang, D. (2015). Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117695"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fcimb.2018.00286","article-title":"Promising antifungal targets against Candida albicans based on ion homeostasis","volume":"8","author":"Li","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/21505594.2016.1197444","article-title":"Targeting Candida albicans filamentation for antifungal drug development","volume":"8","author":"Vila","year":"2017","journal-title":"Virulence"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2672.2007.03617.x","article-title":"Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump","volume":"104","author":"Guo","year":"2008","journal-title":"J. Appl. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"796363","DOI":"10.3389\/fmicb.2021.796363","article-title":"Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against Streptococcus pneumoniae","volume":"12","author":"Khan","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bappy, M.N.I., Robin, T.B., Prome, A.A., Laskar, F.S., Roy, A., Akter, H., and Zinnah, K.M.A. (2022). Subtractive proteomics analysis to uncover the potent drug targets for distinctive drug design of Candida auris. bioRxiv.","DOI":"10.1016\/j.heliyon.2023.e17026"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s40203-018-0040-x","article-title":"Molecular modeling of inhibitors against fructose bisphosphate aldolase from Candida albicans","volume":"6","author":"Souza","year":"2018","journal-title":"Silico Pharmacol."},{"key":"ref_42","first-page":"8280925","article-title":"Epitope-based peptide vaccine design against fructose bisphosphate aldolase of Candida glabrata: An immunoinformatics approach","volume":"2021","author":"Hassan","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Rodicio, R., Schmitz, H.-P., and Heinisch, J.J. (2022). Genetic and physiological characterization of fructose-1, 6-bisphosphate aldolase and glyceraldehyde-3-phosphate dehydrogenase in the crabtree-negative yeast Kluyveromyces lactis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020772"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"719678","DOI":"10.3389\/fmolb.2021.719678","article-title":"Multifunctional fructose 1, 6-bisphosphate aldolase as a therapeutic target","volume":"8","author":"Pirovich","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2217\/FMB.15.47","article-title":"Medically important fungi respond to azole drugs: An update","volume":"10","author":"Zavrel","year":"2015","journal-title":"Future Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Jalal, K., Khan, K., Hassam, M., Abbas, M.N., Uddin, R., Khusro, A., Sahibzada, M.U.K., and Gajdacs, M. (2021). Identification of a Novel Therapeutic Target against XDR Salmonella Typhi H58 Using Genomics Driven Approach Followed up by Natural Products Virtual Screening. Microorganisms, 9.","DOI":"10.3390\/microorganisms9122512"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"106498","DOI":"10.1016\/j.dib.2020.106498","article-title":"Dataset of materia medica in Sowa Rigpa: Tibetan medicine botanicals and Gaw\u00e9 Dorj\u00e9\u2019s classification system","volume":"33","author":"Wangyal","year":"2020","journal-title":"Data Brief"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"376327","DOI":"10.1155\/2013\/376327","article-title":"Indian traditional ayurvedic system of medicine and nutritional supplementation","volume":"2013","author":"Pandey","year":"2013","journal-title":"Evid.Based Complement. Altern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fphar.2018.00029","article-title":"Natural Medicines Used in the Traditional Tibetan Medical System for the Treatment of Liver Diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"153494","DOI":"10.1016\/j.phymed.2021.153494","article-title":"Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients","volume":"84","author":"Devpura","year":"2021","journal-title":"Phytomedicine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s13063-016-1481-3","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Tong Luo Hua Shi capsule, a modernized Tibetan medicine, in patients with rheumatoid arthritis","volume":"17","author":"Liu","year":"2016","journal-title":"Trials"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13063-022-06338-1","article-title":"Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: Protocol for a multi-center, randomized, double-blind, placebo-controlled trial","volume":"23","author":"Shang","year":"2022","journal-title":"Trials"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1745-6215-14-149","article-title":"Comparative effectiveness of a complex Ayurvedic treatment and conventional standard care in osteoarthritis of the knee-study protocol for a randomized controlled trial","volume":"14","author":"Witt","year":"2013","journal-title":"Trials"},{"key":"ref_54","first-page":"7034","article-title":"Phytochemical Compositions Biological Activities of Essential Oil from Xanthium strumarium L.","volume":"20","author":"Iriti","year":"2015","journal-title":"Biomolecules"},{"key":"ref_55","first-page":"69","article-title":"Anti-bacterial effect of essential oil from Xanthium strumarium against shiga toxin-producing Escherichia coli","volume":"62","author":"Soufi","year":"2016","journal-title":"Cell. Mol. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Soulaimani, B., Varoni, E., Iriti, M., Mezrioui, N., Hassani, L., and Abbad, A. (2021). Synergistic Anticandidal Effects of Six Essential Oils in Combination with Fluconazole or Amphotericin B against Four Clinically Isolated Candida Strains. Antibiotics, 10.","DOI":"10.3390\/antibiotics10091049"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"661230","DOI":"10.3389\/fchem.2021.661230","article-title":"Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the h ACE2 Receptor","volume":"9","author":"Dahab","year":"2021","journal-title":"Front. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Brogi, S.J.M. (2019). Computational approaches for drug discovery. Molecules, 24.","DOI":"10.3390\/molecules24173061"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Yasmin, A., Basharat, Z., and Safdar, N. (2019). In-silico Approach to Target Cancer Cell DNA Repair Pathway. Phytochemistry: An In-Silico and In-Vitro Update, Springer.","DOI":"10.1007\/978-981-13-6920-9_20"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0006-291X(90)91544-3","article-title":"Chelerythrine is a potent specific inhibitor of protein kinase, C","volume":"172","author":"Herbert","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3389\/fphar.2018.01047","article-title":"Chelerythrine attenuates the inflammation of lipopolysaccharide-induced acute lung inflammation through NF-\u03baB signaling pathway mediated by Nrf2","volume":"9","author":"Fan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1124\/dmd.107.015644","article-title":"Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs","volume":"35","author":"Sinha","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/00498250600761662","article-title":"Prediction of metabolic drug clearance in humans: In vitro\u2013in vivo extrapolation vs. allometric scaling","volume":"36","author":"Shiran","year":"2006","journal-title":"Xenobiotica"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1208\/s12248-008-9079-7","article-title":"Predicting pharmacokinetics of drugs using physiologically based modeling\u2014Application to food effects","volume":"11","author":"Parrott","year":"2009","journal-title":"AAPS J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2165\/00003088-200645120-00006","article-title":"Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling","volume":"45","author":"Jones","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1021\/mp8000155","article-title":"Applications of physiologically based absorption models in drug discovery and development","volume":"5","author":"Parrott","year":"2008","journal-title":"Mol. Pharm."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/11\/1743\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:06:12Z","timestamp":1760144772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/11\/1743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,30]]},"references-count":66,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["life12111743"],"URL":"https:\/\/doi.org\/10.3390\/life12111743","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,30]]}}}